Health

First Batch Of Covid-19 Vaccines “Won’t Be Ideal” Said Bill Gates

Nowadays, everyone is working every fiber of their being to make sure that a vaccine for the highly dangerous virus at this moment that is Covid-19 could be produced and finally can be used worldwide to end this dreading pandemic situation. Many parties such as scientists, laboratory workers, and others are working hand in hand to come up with the vaccine.

Other than all these important parties, there is also one particular person who takes this effort seriously and that person is Bill Gates. Bill Gates has been involved with the finding of vaccine for Covid-19 since the coronavirus outbreak and he involved more than any other philanthropist. He even has reached the point where he would found himself caught up in the middle of conspiracy theories that he actually planted the virus himself for his own evil purposes.

More than $350 million has been pledged by The Bill & Melinda Gates Foundation to support the development of the vaccine at several pharma companies such as Novavax, AstraZeneca, and also Johnson & Johnson. Even most of the individuals in the medical community have agreed to test the first batch of vaccine by the end of this year, Bill Gates warned them that the vaccine might not be powerful enough to solve all the serious problems at one go.

“The initial vaccine won’t be ideal in terms of its effectiveness against sickness and transmission,” Gates said in a new interview with Bloomberg. “It may not have a long duration, and it will mainly be used in rich countries as a stopgap measure.”

The positive point of view that can be taken in this situation would be the vaccine would be widely available and the effective vaccines will likely arrive next year when multiple vaccines get approved and the manufacturing process ramps up. “With so many companies working on it, we can afford quite a few failures and still have something with low cost and long duration,” Gates added.

A handful of vaccine candidates such as AstraZeneca’s AZD1222 and Moderna’s mRNA-1273, have started final human trials. Right now, the U.S. and a few European countries are racing to seal deals with vaccine developers, committing to purchase hundreds of millions of doses even though their vaccines haven’t been proven safe and effective.

“Every call I’m on with the pharma leaders and the leaders of countries is with the goal of, ‘Hey, we need everybody to be protected,’” Gates said. “We’ve funded more research and development than any country, but on factories and procurement, we’ve only taken care of ourselves.” “The innovations in therapeutics will start to cut the death rate, but the true end will come from the spread of natural infections and the vaccine giving us herd immunity,” he added. “For rich countries, that will be sometime next year, ideally in the first half.”

Sources: Observer

Adib Mohd

Recent Posts

Kamatto Expands in Malaysia with Upgraded Classic II Mat and Car Perfume

Automotive accessories brand Kamatto is expanding its product range in Malaysia with the launch of… Read More

2 hours ago

The Disney Adventure Arrives in Singapore, Disney Cruise Line’s First Ship to Homeport in Asia

Disney Cruise Line made waves in Asia as the Disney Adventure arrived at its new… Read More

2 hours ago

Samsung Electronics Marks 20 Consecutive Years as the World’s No.1 TV Brand

Samsung Electronics has secured its spot as the world’s No.1 TV brand once again. This… Read More

5 hours ago

PUMA and McLaren Racing Brought Southeast Asia Together for High-Speed Style at Ignition Beach

Global sports brand PUMA teamed up with the McLaren Formula 1 Team to bring race-week… Read More

6 hours ago

HARTA Presents HIKAYAT by Noor ‘Aishah Abdul Rahman (Noura AR)

HARTA is back with HIKAYAT, an autobiographical exhibition by Noor ‘Aishah Abdul Rahman (Noura AR).… Read More

1 day ago

Sonos Returns to Its Core: Effortless Sound with Two Essential Speakers

Sonos (Nasdaq: SONO) today introduced Sonos PlayTM and Sonos Era 100TM SL, two new speakers… Read More

1 day ago

This website uses cookies.